Dupixent stirs Sanofi’s growth as vaccine sales cool
Dupixent’s Q3 sales increased by 26.2%, breaking through the €4bn ceiling for the first time in a single quarter.
Business & Regulation
Roche in ongoing discussions with US government over drug pricing, CEO says
Infertility treatment amongst first drugs included on FDA’s new priority voucher scheme
Drugmakers point to US expansion plans amid Trump’s 100% drug tariff
Trump tasks FDA to crack down on misleading drug advertising
Novo Nordisk slashes 11% of workforce as Eli Lilly pressure tightens
Bavarian Nordic boosts 2025 guidance as takeover offer looms
CSL slashes 15% of workforce and offshoots vaccine division
